https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-12-02 / Adv Mater 2021 Jan;33(4):e2004788
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-12-02 / Adv Mater 2021 Jan;33(4):e20047882020-12-02 00:00:002020-12-02 00:00:00Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-28 / Cancers (Basel) 2020 Nov;12(12)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-28 / Cancers (Basel) 2020 Nov;12(12)2020-11-28 00:00:002022-10-30 16:29:37Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-22 / Biomedicines 2020 Nov;8(11)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-22 / Biomedicines 2020 Nov;8(11)2020-11-22 00:00:002021-11-15 19:49:33Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-17 / Cancers (Basel) 2020 Nov;12(11)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-17 / Cancers (Basel) 2020 Nov;12(11)2020-11-17 00:00:002024-08-26 09:18:25A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-16 / Int J Mol Sci 2020 Nov;21(22)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-16 / Int J Mol Sci 2020 Nov;21(22)2020-11-16 00:00:002020-12-07 09:22:05Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-13 / Biomed Res Int 2020;2020:8814878
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-13 / Biomed Res Int 2020;2020:88148782020-11-13 00:00:002020-11-13 00:00:00Modulated Electrohyperthermia: A New Hope for Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-27 / Front Oncol 2020;10:605633
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-27 / Front Oncol 2020;10:6056332020-10-27 00:00:002020-10-27 00:00:00Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-26 / Oncologist 2020 Oct;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-26 / Oncologist 2020 Oct;2020-10-26 00:00:002020-10-26 00:00:00Emerging Immunotherapies in the Treatment of Brain Metastases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-26 / Front Oncol 2020;10:536700
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-26 / Front Oncol 2020;10:5367002020-10-26 00:00:002020-10-26 00:00:00High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-14 / Nat Commun 2020 10;11(1):5173
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-14 / Nat Commun 2020 10;11(1):51732020-10-14 00:00:002020-10-14 00:00:00Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients
